INTERNATIONAL PATENT: SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD., 沈阳三生制药有限责任公司 FILES APPLICATION FOR "METHOD FOR PREPARING LOW-IMMUNOGENICITY INDUCED PLURIPOTENT STEM CELL, METHOD FOR PREPARING HEMATOPOIETIC STEM/PROGENITOR CELL INDUCED THEREFROM AND USE THEREOF"

Posted On: 2026-02-08

GENEVA, Feb. 8 -- SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. (No.3, A1, Road 10, Shenyang Economy & Technology Development ZoneShenyang, Liaoning 110027), 沈阳三生制药有限责任公司 (中国辽宁省沈阳市沈阳经济技术开发区10号路1甲3号) filed a patent application (PCT/CN2025/110899) for "METHOD FOR PREPARING LOW-IMMUNOGENICITY INDUCED PLURIPOTENT STEM CELL, METHOD FOR PREPARING HEMATOPOIETIC STEM/PROGENITOR CELL INDUCED THEREFROM, AND USE THEREOF" on Jul 28, 2025. With publication no. WO/2026/026711, the details related to the patent application was publ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD., 沈阳三生制药有限责任公司 FILES APPLICATION FOR "METHOD FOR PREPARING LOW-IMMUNOGENICITY INDUCED PLURIPOTENT STEM CELL, METHOD FOR PREPARING HEMATOPOIETIC STEM/PROGENITOR CELL INDUCED THEREFROM AND USE THEREOF"